Drexel Morgan & Co’s Abbott ABT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.51M Hold
34,181
0.51% 30
2025
Q4
$4.28M Hold
34,181
0.67% 21
2025
Q3
$4.58M Hold
34,181
0.72% 22
2025
Q2
$4.65M Hold
34,181
0.83% 21
2025
Q1
$4.53M Hold
34,181
0.95% 20
2024
Q4
$3.87M Hold
34,181
0.8% 21
2024
Q3
$3.9M Hold
34,181
0.72% 22
2024
Q2
$3.55M Buy
34,181
+547
+2% +$58K 0.76% 22
2024
Q1
$3.82M Buy
33,634
+357
+1% +$40.9K 0.79% 21
2023
Q4
$3.66M Buy
33,277
+353
+1% +$35.3K 0.85% 21
2023
Q3
$3.19M Hold
32,924
0.87% 21
2023
Q2
$3.59M Hold
32,924
0.93% 22
2023
Q1
$3.33M Hold
32,924
0.84% 23
2022
Q4
$3.61M Buy
32,924
+475
+1% +$49.2K 0.74% 23
2022
Q3
$3.14M Hold
32,449
0.75% 22
2022
Q2
$3.53M Hold
32,449
0.97% 20
2022
Q1
$3.84M Hold
32,449
1.12% 19
2021
Q4
$4.57M Hold
32,449
1.32% 18
2021
Q3
$3.83M Sell
32,449
-325
-1% -$39.9K 1.23% 18
2021
Q2
$3.8M Hold
32,774
1.12% 22
2021
Q1
$3.93M Hold
32,774
1% 28
2020
Q4
$3.59M Hold
32,774
0.98% 26
2020
Q3
$3.57M Sell
32,774
-56
-0.2% -$5.68K 1.25% 25
2020
Q2
$3M Buy
32,830
+5
+0% +$452 1.13% 25
2020
Q1
$2.59M Buy
32,825
+10,267
+46% +$857K 1% 26
2019
Q4
$1.96M Sell
22,558
-4,431
-16% -$371K 1.47% 22
2019
Q3
$2.26M Buy
26,989
+57
+0.2% +$4.84K 1.74% 20
2019
Q2
$2.27M Sell
26,932
-986
-4% -$77.6K 1.75% 19
2019
Q1
$2.23M Buy
27,918
+675
+2% +$50.2K 1.98% 16
2018
Q4
$1.97M Buy
27,243
+1,001
+4% +$70.3K 1.97% 16
2018
Q3
$1.93M Sell
26,242
-72
-0.3% -$4.73K 1.69% 19
2018
Q2
$1.6M Sell
26,314
-1,504
-5% -$91.2K 1.61% 26
2018
Q1
$1.67M Buy
27,818
+271
+1% +$16.3K 1.74% 23
2017
Q4
$1.57M Buy
27,547
+482
+2% +$26.7K 1.53% 26
2017
Q3
$1.44M Sell
27,065
-789
-3% -$39.6K 1.48% 27
2017
Q2
$1.35M Buy
27,854
+402
+1% +$18.2K 1.39% 31
2017
Q1
$1.22M Buy
27,452
+7,666
+39% +$331K 1.35% 34
2016
Q4
$760K Buy
19,786
+650
+3% +$25.8K 0.9% 38
2016
Q3
$809K Hold
19,136
0.9% 40
2016
Q2
$752K Sell
19,136
-3,250
-15% -$129K 0.85% 44
2016
Q1
$937K Buy
22,386
+280
+1% +$11.1K 1.1% 38
2015
Q4
$993K Buy
22,106
+220
+1% +$9.71K 1.1% 36
2015
Q3
$881K Sell
21,886
-61
-0.3% -$2.88K 1.14% 33
2015
Q2
$1.08M Sell
21,947
-1,185
-5% -$56.9K 1.28% 25
2015
Q1
$1.07M Buy
23,132
+520
+2% +$23.9K 1.14% 27
2014
Q4
$1.02M Hold
22,612
1.15% 30
2014
Q3
$941K Sell
22,612
-278
-1% -$11.8K 1.14% 30
2014
Q2
$937K Buy
22,890
+580
+3% +$22.8K 1.13% 29
2014
Q1
$859K Hold
22,310
1.08% 31
2013
Q4
$856K Sell
22,310
-317
-1% -$11.7K 1.15% 31
2013
Q3
$751K Buy
22,627
+11,368
+101% +$399K 1.03% 33
2013
Q2
$393K Buy
+11,259
New +$413K 0.65% 45

Other funds holding ABT

Drexel Morgan & Co's ABT Position: Q1 2026 in Review

Drexel Morgan & Co held its Abbott (ABT) position steady in Q1 2026 at 34,181 shares worth $3.51M. The position accounts for 0.51% of the portfolio, ranked #30.

Drexel Morgan & Co first reported a position in ABT in Q2 2013 and has held it in 52 quarters since. The position peaked at $4.65M in Q2 2025. 3,083 funds tracked by Wall St. Rank hold ABT as of Q1 2026.

  • Drexel Morgan & Co held 34,181 shares of Abbott worth $3.51M as of Q1 2026.
  • Drexel Morgan & Co left its Abbott share count unchanged in Q1 2026.
  • Abbott made up 0.51% of Drexel Morgan & Co's portfolio in Q1 2026, its #30 holding.
  • Drexel Morgan & Co first reported a position in Abbott in Q2 2013 and has held it in 52 quarters since.
  • Drexel Morgan & Co's Abbott position peaked at $4.65M in Q2 2025.
  • 3,083 funds tracked by Wall St. Rank held Abbott as of Q1 2026.

Based on Drexel Morgan & Co's 13F filing for Q1 2026, filed 11 May 2026.